Current Issue

Vol. 16 No. 1 (2025)
View Vol. 16 No. 1 (2025)

Painting by Juliane Mercante, São Paulo, Brazil. This artwork was chosen as the symbol of Cluster Headache Awareness Day, observed on March 21, 2025, by the Brazilian Association for Cluster Headache and Migraine (ABRACES).

Published: 2025-03-31

Editorial

  • Physiotherapy Committee of Brazilian Headache Society is represented in the Physiotherapy Specialist Interest Group

    Debora Bevilaqua Grossi, Daniella Araújo de Oliveira , Gwendolen Jull, Zhiqi Liang, Kerstin Luedtke (Author)
    1-2

    Views: 189
    DOI: https://doi.org/10.48208/HeadacheMed.2025.1

Review

  • Acute and long-term neurological manifestations of Covid-19: insights from virology and neurology

    Kirolos Eskandar (Author)
    3-13

    Views: 165
    DOI: https://doi.org/10.48208/HeadacheMed.2025.2

  • Migraine and brain tumors: a bibliometric analysis and narrative review

    Heba Ramadan (Author)
    14-22

    Views: 148
    DOI: https://doi.org/10.48208/HeadacheMed.2025.3

  • Best time for the application of the "blood patch" technique for post-spinal anesthesia headache: a systematic review

    Ana Letícia Borghetti, Alan Christmann Fröhlich (Author)
    23-27

    Views: 120
    DOI: https://doi.org/10.48208/HeadacheMed.2025.4

  • Dialysis headache: a systematic review and meta-analysis

    Heba Ramadan (Author)
    24-37 / 38-43

    Views: 218
    DOI: https://doi.org/10.48208/HeadacheMed.2025.5

Original

  • Descriptive epidemiological study of migraine in three emergency departments of the public health network of Chile

    Cristián Neira Osses, Olga Benavides Canales, Mérida Terán Jiménez, Constanza Ramírez Pérez, Félix Carreño Rojas, Ramiro Fernández Calderón, Danilo Aranzaes Valdés, Paulina Meza Castro, Diego Morales Vidal (Author)
    44-50

    Views: 124
    DOI: https://doi.org/10.48208/HeadacheMed.2025.6

  • Hyperacusis and plasma levels of cytokines in migraine

    Franciela Massi de Castro, Aline Vitali da Silva, Valéria Aparecida Bello, Regina Célia Poli (Author)
    51-57

    Views: 195
    DOI: https://doi.org/10.48208/HeadacheMed.2025.7

  • Menstrual migraine in university students

    Isabela Montegutti Coan, Maria Luiza Del Prato Hoffmann, Tatiana Pizzolotto Bruch (Author)
    58-64

    Views: 148
    DOI: https://doi.org/10.48208/HeadacheMed.2025.8

Case Report

  • Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC

    Joe Muñoz-Cerón, Ildefonso Rodríguez, Carolina Guerra, Karina Vélez, Natalia Hernández, Paula Nieto-Rodríguez, Daniela Gomez Barrera (Author)
    65-70

    Views: 120
    DOI: https://doi.org/10.48208/HeadacheMed.2025.9

Commented Article

  • Petasites hybridus: evidence 1A on migraine prophylaxis

    Carlos Alberto Bordini (Author)
    71-74

    Views: 184
    DOI: https://doi.org/10.48208/HeadacheMed.2025.10

  • Prevention of migraine in children and adolescents: results of an open-label study with special extract of Petasites hybridus root

    Alexandre Kaup (Author)
    75-80

    Views: 147
    DOI: https://doi.org/10.48208/HeadacheMed.2025.11
View All Issues

Headache Medicine (p-ISSN 2178-7468 and e-ISSN 2763-6178), created in 2010, is the scientific publication of the Brazilian Headache Society (SBCe). During the period 1994-2009 it was titled Migraneas & Cefaleias (ISSN 1678-6270).

Headache Medicine aims to attract specialists in ​​headache, working in continuing education with clinical and experimental publications. Also aiming to stimulate research with animal models to better understand the pathophysiology of diseases and drug action. Monitor innovations in the area of ​​headache diagnosis and treatment.

Areas of interest: The editorial board accepts manuscripts in English on headache and orofacial pain. Our scope encompasses clinical and experimental, qualitative and quantitative research.

Types of articles: Articles are published in each edition in ordered sections: editorial, opinion, reviews, original, clinical correspondence, case report, image in headache, and thesis.

Periodicity: It publishes four issues per year. From 2023 on, the Headache Medicine will be published continuously.

All articles are peer-reviewed (simple blind), and the editor responsible for the evaluation process is informed in the published article.

Author charges: Headache Medicine is an open-access journal and does not charge fees for article submission, review, and publication. All processes are performed electronically.

The responsibility for the scientific information in the articles is the exclusive responsibility of the authors. Headache Medicine content is licensed under a Creative Commons Attribution 4.0 International (CC BY).

Headache Medicine respects the Ethical Conduct and Good Publication Practices (Principles of Transparency and Best Practice in Scholarly Publishing) published by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME), the Singapore and Hong Kong Declaration on Research Integrity.

Headache Medicine uses the LOCKSS protocol as a digital archiving policy for document preservation.